CD40 immunotherapy for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDA) is a highly aggressive and lethal cancer which is poorly responsive to standard therapies. Although the PDA tumor microenvironment is considered especially immunosuppressive, recent data mostly from genetically engineered and other mouse models of the disease s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Vonderheide, Robert H., Bajor, David L., Winograd, Rafael, Evans, Rebecca A., Bayne, Lauren J., Beatty, Gregory L.
Formato: Artigo
Idioma:Inglês
Publicado: Springer-Verlag 2013
Assuntos:
Focussed Research Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3731141/
https://ncbi.nlm.nih.gov/pubmed/23589109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-013-1427-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares